PET–CT allows simultaneous capture and co-registration of functional and anatomical data. Here, Australian-based authors outline the current clinical status of this 'functional imaging' in renal cell carcinoma. New radiotracers and approaches—including radiolabeled monoclonal antibodies and imaging of tumor hypoxia—are touched on, and areas of future research discussed.
- Nathan Lawrentschuk
- Ian D. Davis
- Andrew M. Scott
